Paper31324697
Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry.
Wang PF and 2 others. Drug Metab Dispos, 2019. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry. Papers, record 31324697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31324697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzoxazines | Major topic |
| Cytochrome P-450 CYP2B6 | Major topic |
| HIV Infections | Major topic |
| Reverse Transcriptase Inhibitors | Major topic |
| Alkynes | |
| Animals | |
| Cell Line | |
| Cyclopropanes | |
| Humans | |
| Insecta | |
| Polymorphism, Single Nucleotide | |
| Recombinant Proteins | |
| Stereoisomerism |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 DA014211 | NIDA NIH HHS | United States | R01DA014211 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 31562132 | Correction to "Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry". | https://conductscience.org/library/papers/31562132 |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18294336 | Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers. | Br J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18294336 | PubMed |
| 2 | 18645035 | Multiple substrate binding by cytochrome P450 3A4: estimation of the number of bound substrate molecules. | Drug Metab Dispos | 2008 | https://conductscience.org/library/papers/18645035 | PubMed |
| 3 | 24497997 | Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes. | PLoS One | 2014 | https://conductscience.org/library/papers/24497997 | PubMed |
| 4 | 18621926 | Investigation of the mechanisms underlying the differential effects of the K262R mutation of P450 2B6 on catalytic activity. | Mol Pharmacol | 2008 | https://conductscience.org/library/papers/18621926 | PubMed |
| 5 | 19239339 | Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19239339 | PubMed |
| 6 | 21821736 | Q172H replacement overcomes effects on the metabolism of cyclophosphamide and efavirenz caused by CYP2B6 variant with Arg262. | Drug Metab Dispos | 2011 | https://conductscience.org/library/papers/21821736 | PubMed |
| 7 | 30085944 | Stereoselective Ketamine Metabolism by Genetic Variants of Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase. | Anesthesiology | 2018 | https://conductscience.org/library/papers/30085944 | PubMed |
| 8 | 17259447 | Enantiomeric metabolic interactions and stereoselective human methadone metabolism. | J Pharmacol Exp Ther | 2007 | https://conductscience.org/library/papers/17259447 | PubMed |
| 9 | 16392090 | Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance. | Clin Infect Dis | 2006 | https://conductscience.org/library/papers/16392090 | PubMed |
| 10 | 27600044 | Inhibition of Cytochrome P450 2B6 Activity by Voriconazole Profiled Using Efavirenz Disposition in Healthy Volunteers. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27600044 | PubMed |
| 11 | 23166317 | Compartmentalization and antiviral effect of efavirenz metabolites in blood plasma, seminal plasma, and cerebrospinal fluid. | Drug Metab Dispos | 2013 | https://conductscience.org/library/papers/23166317 | PubMed |
| 12 | 9241656 | Examination of purported probes of human CYP2B6. | Pharmacogenetics | 1997 | https://conductscience.org/library/papers/9241656 | PubMed |
| 13 | 10681367 | In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model. | Drug Metab Dispos | 2000 | https://conductscience.org/library/papers/10681367 | PubMed |
| 14 | 26655325 | CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women. | AIDS Res Hum Retroviruses | 2016 | https://conductscience.org/library/papers/26655325 | PubMed |
| 15 | 25611810 | Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa. | Br J Clin Pharmacol | 2015 | https://conductscience.org/library/papers/25611810 | PubMed |
| 16 | 9862748 | Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6. | J Pharmacol Exp Ther | 1999 | https://conductscience.org/library/papers/9862748 | PubMed |
| 17 | 26686 | The effect of pH on the cooperative behavior of aspartate transcarbamylase from Escherichia coli. | J Biol Chem | 1978 | https://conductscience.org/library/papers/26686 | PubMed |
| 18 | 28145050 | Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial. | HIV Med | 2017 | https://conductscience.org/library/papers/28145050 | PubMed |
| 19 | 16611850 | Metabolism of efavirenz and 8-hydroxyefavirenz by P450 2B6 leads to inactivation by two distinct mechanisms. | J Pharmacol Exp Ther | 2006 | https://conductscience.org/library/papers/16611850 | PubMed |
| 20 | 21659470 | Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex. | J Pharmacol Exp Ther | 2011 | https://conductscience.org/library/papers/21659470 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42296571 | Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/42296571 | PubMed |
| 42196482 | Efavirenz-Altered Gut-Microbiota, Tph1, and Systemic 5-HT Levels: Could They Affect Depression Mechanisms in Mice? | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196482 | PubMed |
| 42027046 | Stereoselective Biotransformation: Transfer of Learning to Advance Drug Metabolism and Biocatalysis. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42027046 | PubMed |
| 41948624 | Strengthening Pharmacogenomics Implementation in Africa: Challenges and Opportunities - A Narrative Review. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/41948624 | PubMed |
| 41805453 | Changes in Metabolic Parameters After Switching From Efavirenz to Dolutegravir-Based Regimen: A Cohort Study in Thai People Living With HIV. | J Int Assoc Provid AIDS Care | 2026 | https://conductscience.org/library/papers/41805453 | PubMed |
| 41674639 | Distinct biochemical phenotypes of HIV exposed infants driven by antiviral medication. | medRxiv | 2026 | https://conductscience.org/library/papers/41674639 | PubMed |
| 41149818 | Pharmacogenomics in Orofacial Clefts Care: Insights from Whole-Genome Sequencing of Case-Parents Trios. | J Pers Med | 2025 | https://conductscience.org/library/papers/41149818 | PubMed |
| 41061300 | Applicability domain-expansion studies for machine learning models reveal new inhibitors of CYP2B6. | Drug Metab Dispos | 2025 | https://conductscience.org/library/papers/41061300 | PubMed |
| 40968422 | Application of Physiologically Based Pharmacokinetic Modeling in the Research of Anti-HIV Drugs. | Curr Drug Metab | 2025 | https://conductscience.org/library/papers/40968422 | PubMed |
| 40851704 | Population Pharmacokinetic-Pharmacogenetic (PopPK-PGx) Model of Efavirenz in HIV-1-Infected Patients. | Cureus | 2025 | https://conductscience.org/library/papers/40851704 | PubMed |
| 40110576 | Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions. | Precis Clin Med | 2025 | https://conductscience.org/library/papers/40110576 | PubMed |
| 39768746 | High Prevalence of Severe Depression in Mexican Patients Diagnosed with HIV Treated with Efavirenz and Atazanavir: Clinical Follow-Up at Four Weeks and Analysis of TPH2 SNPs. | J Clin Med | 2024 | https://conductscience.org/library/papers/39768746 | PubMed |
| 39735593 | Overweight and Obesity Among People Living With HIV on Dolutegravir- and Efavirenz-Based Therapies: A Comparative Cross-Sectional Study. | AIDS Res Treat | 2024 | https://conductscience.org/library/papers/39735593 | PubMed |
| 39371070 | Liver Damage During Treatment with Reverse-Transcriptase Inhibitors in HIV Patients. | Curr Health Sci J | 2024 | https://conductscience.org/library/papers/39371070 | PubMed |
| 39339201 | PBPK Modeling of Lamotrigine and Efavirenz during Pregnancy: Implications for Personalized Dosing and Drug-Drug Interaction Management. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39339201 | PubMed |
| 39066420 | Safety and Efficacy of Antiviral Drugs and Vaccines in Pregnant Women: Insights from Physiologically Based Pharmacokinetic Modeling and Integration of Viral Infection Dynamics. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39066420 | PubMed |
| 38931468 | Oral Administration of Efavirenz Dysregulates the Tph2 Gene in Brain Serotonergic Areas and Alters Weight and Mood in Mice. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38931468 | PubMed |
| 38396919 | 7,8-Dihydroxy Efavirenz Is Not as Effective in CYP46A1 Activation In Vivo as Efavirenz or Its 8,14-Dihydroxy Metabolite. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38396919 | PubMed |
| 38332525 | Body weight and blood pressure changes on dolutegravir-, efavirenz- or atazanavir-based antiretroviral therapy in Zimbabwe: a longitudinal study. | J Int AIDS Soc | 2024 | https://conductscience.org/library/papers/38332525 | PubMed |
| 38135504 | Natural Products Inhibition of Cytochrome P450 2B6 Activity and Methadone Metabolism. | Drug Metab Dispos | 2024 | https://conductscience.org/library/papers/38135504 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP2B6 | 1555 | PubTator's text mining | https://conductscience.org/library/genes/1555 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31324697
GET https://conductscience.org/api/papers/v1/31324697/references?page=2